Breast cancer is second only to lung cancer as a leading cause of cancer mortality in women. In women with metastatic, hence, essentially incurable disease, we strive to find effective chemotherapeutic regimens that offer a
Cynthia Frankel, RN
Advertisement
Articles by Cynthia Frankel, RN
Advertisement
Latest Updated Articles
- Rationale for Trials Studying Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer
Published: October 1st 1997 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Antiemetic Regimen Limits Chemo-Induced Nausea/Vomiting in Multiple Myeloma
2
Casdatifan Monotherapy Achieves Clinical Activity in Late-Line Kidney Cancer
3
Addressing Early Talquetamab Toxicity Concerns
4
FDA Grants Priority Review to BLA for Orca-T in Hematologic Malignancies
5
